France· FR:64410713
ACIDE ZOLEDRONIQUE BIOGARAN 4 mg/100 ml, solution pour perfusion
A medicinal product, registered in France by BIOGARAN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- BIOGARAN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930227152poche(s) polypropylène de 100 mlEUR 98.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ACIDE in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsZoledronic Acid Hospira 4 mg/ 100 ml, oplossing voor infusiePfizer Europe MA EEIG
- FinlandAclastaParanova Oy
- United StatesReclastSandoz Inc
- United KingdomAclasta 5mg/100ml solution for infusion bottlesSandoz Ltd
- BelgiumAcide Zoledronique Regiomedica 4 mg/5 mlRegiomedica
- GermanyAszoraAnwerina Deutschland Gmbh
- CzechiaACLASTASandoz Pharmaceuticals d.d., Ljubljana
- SpainACIDO ZOLEDRONICO ACCORD 4 MG/100 ML SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
- Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
- Cyprus · Nordeloz, Zoledronic Acid Altan
- Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
- Germany · Aszora, Clastizol
- Denmark · Zoledo, Zoledronsyre Fresenius Kabi
- Estonia · Zoledronic Acid Fresenius Kabi
- Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Finland · Zobiore, Zoledronic Acid Fresenius Kabi
- United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
- Greece · Bonevin, Nordeloz
- Croatia · Zolenat
- Hungary · Osporil, Zoledronsav Fresenius Kabi
- Ireland · Zerlinda, Zoledronic Acid
- Iceland · Aclasta, Aszora
- Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
- Liechtenstein · Aclasta, Zoledronic Acid Accord
- Lithuania · Zoledronic Acid Fresenius Kabi
- Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
- Latvia · Zoledronic Acid Fresenius Kabi
- Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
- Norway · Aclasta, Zoledo
- Poland · Osporil, Zerlinda
- Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
- Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
- Sweden · Zerlinda, Zoledronic Acid Accord
- Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
- Slovakia · Kyselina, Kyselina Zoledrónová Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df3d1dbf-9143-4ce0-84ed-d72eb8e13e90 GET /v1/drugs/df3d1dbf-9143-4ce0-84ed-d72eb8e13e90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64410713",
"date_amm": "2014-02-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ACIDE.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.